RANI icon

Rani Therapeutics
RANI

Overview Fund Trends Analyst Outlook Journalist POV

34 hedge funds and large institutions have $6.96M invested in Rani Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

47% less capital invested

Capital invested by funds: $13.3M → $6.96M (-$6.29M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $17K

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$17K
Net Calls
Net Calls Change

Top Buyers

1
+$142K
2
+$112K
3
+$75.8K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$35.8K
5
AWM
Activest Wealth Management
Florida
+$21.3K

Top Sellers

1
-$190K
2
-$170K
3
-$81K
4
Citadel Advisors
Citadel Advisors
Florida
-$36.9K
5
ASGS
Alpha Square Group S
New York
-$31.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$9.65K
27
$6.78K
28
$2.19K
29
$2K
30
$1.96K
31
$678
32
$204
33
$7
34
–
35
–
36
–
37
–
1
2